Skip to main content
. Author manuscript; available in PMC: 2013 Aug 21.
Published in final edited form as: Brain Res. 2012 Jun 29;1469:129–135. doi: 10.1016/j.brainres.2012.06.005

Fig. 2.

Fig. 2

Clavulanic acid protects against MPP+ induced ROS generation and loss in mitochondrial membrane potential: (A) SH-SY5Y cells were treated with 500 μM MPP+ in the presence or absence of clavulanic acid for 24 h and then loaded with DCFH-DA to measure ROS generation. (B) Mitochondrial membrane potential was measured by using Rhodamine 123. Cells were loaded with Rhodamine 123 after the respective treatment to measure the mitochondrial membrane potential. Data are expressed as means ±SD (n=6). *p<0.05 compared with respective controls.